Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 9046
Corporate User License Price USD 375
Corporate User License Price INR 27139
Site License Price USD 250
Site License Price INR 18093
Request a Quote

Report Title

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review



Executive Summary

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lonza Group Ltd (Lonza) is a biopharmaceutical company that manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company offers active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers, vitamin B compounds, industrial preservatives, microbial control solutions and organic personal care ingredients. It also provides custom development and custom manufacturing services to its clients. Lonza's client base includes professionals in the biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; distributors; formulators and service companies. The company's key markets include bioresearch, nutrition, pharma and biotech, microbial control, agriculture, materials science and personal care industries. It operates several manufacturing and research and development (R&D) facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.

Lonza Group Ltd Key Recent Developments

Feb 27,2017: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

Feb 10,2017: Lonza to Showcase Portfolio of Primary Cells and RAFT 3D Culture System to Support Cancer Scientists at AACR Annual Meeting

Jan 25,2017: Lonza Reports Record-Breaking Financial Performance, Resulting in 24.2% CORE EBIT Growth, Driven by Pharma and Biotech

Jan 25,2017: Lonza Appoints Fridtjof Helemann, CHRO, to Executive Committee

Sep 07,2016: Lonza Releases Second-Generation Immunogenicity Assessment and Optimization Platform for Development of Therapeutic Proteins, Vaccines and Cell Therapies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Lonza Group Ltd-Key Facts 6

Lonza Group Ltd-Key Employees 7

Lonza Group Ltd-Key Employee Biographies 8

Lonza Group Ltd-Key Operational Employees 9

Lonza Group Ltd-Major Products and Services 10

Lonza Group Ltd-History 13

Lonza Group Ltd-Company Statement 20

Lonza Group Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 24

Section 2-Company Analysis 26

Lonza Group Ltd-Business Description 26

Lonza Group Ltd-Corporate Strategy 27

Lonza Group Ltd-SWOT Analysis 28

SWOT Analysis-Overview 28

Lonza Group Ltd-Strengths 28

Lonza Group Ltd-Weaknesses 29

Lonza Group Ltd-Opportunities 30

Lonza Group Ltd-Threats 31

Lonza Group Ltd-Key Competitors 32

Section 3-Company Financial Ratios 33

Financial Ratios-Capital Market Ratios 33

Financial Ratios-Annual Ratios 34

Performance Chart 37

Financial Performance 37

Financial Ratios-Interim Ratios 38

Financial Ratios-Ratio Charts 39

Section 4-Company's Lifesciences Financial Deals and Alliances 40

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 41

Lonza Group Ltd, Recent Deals Summary 42

Section 5-Company's Recent Developments 43

Feb 27, 2017: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility 43

Feb 10, 2017: Lonza to Showcase Portfolio of Primary Cells and RAFT 3D Culture System to Support Cancer Scientists at AACR Annual Meeting 44

Jan 25, 2017: Lonza Reports Record-Breaking Financial Performance, Resulting in 24.2% CORE EBIT Growth, Driven by Pharma and Biotech 45

Jan 25, 2017: Lonza Appoints Fridtjof Helemann, CHRO, to Executive Committee 47

Sep 07, 2016: Lonza Releases Second-Generation Immunogenicity Assessment and Optimization Platform for Development of Therapeutic Proteins, Vaccines and Cell Therapies 48

Aug 31, 2016: Lonza to Demonstrate Capabilities in Non-Viral or Viral CAR-T Research and Manufacturing at CAR-TCR Summit 49

Jul 12, 2016: New e-Learning Module in the Lonza QC Insider Toolbox Helps Scientists Overcome Interference in the Bacterial Endotoxins Test 50

May 17, 2016: Lonza CytoSMART Lab Free-Trial Initiative Launched 51

May 10, 2016: Rodolfo Savitzky appointed as new CFO for Lonza to succeed Toralf Haag who was appointed as CFO of the Voith in Germany 52

Apr 26, 2016: Lonza Reports Record First Quarter 53

Section 6-Appendix 54

Methodology 54

Ratio Definitions 54

About GlobalData 58

Contact Us 58

Disclaimer 58

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Lonza Group Ltd, Performance Chart (2012-2016) 37

Lonza Group Ltd, Ratio Charts 39

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 41

List of Tables

Lonza Group Ltd, Key Facts 6

Lonza Group Ltd, Key Employees 7

Lonza Group Ltd, Key Employee Biographies 8

Lonza Group Ltd, Key Operational Employees 9

Lonza Group Ltd, Major Products and Services 10

Lonza Group Ltd, History 13

Lonza Group Ltd, Subsidiaries 22

Lonza Group Ltd, Joint Venture 24

Lonza Group Ltd, Key Competitors 32

Lonza Group Ltd, Ratios based on current share price 33

Lonza Group Ltd, Annual Ratios 34

Lonza Group Ltd, Annual Ratios (Cont...1) 35

Lonza Group Ltd, Annual Ratios (Cont...2) 36

Lonza Group Ltd, Interim Ratios 38

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 41

Lonza Group Ltd, Recent Deals Summary 42

Currency Codes 54

Capital Market Ratios 54

Equity Ratios 55

Profitability Ratios 55

Cost Ratios 56

Liquidity Ratios 56

Leverage Ratios 57

Efficiency Ratios 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Lonza Group Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand